First comprehensive report of impact of genomic alterations, chemotherapy, targeted therapy and immunotherapy on outcomes in the genomics driven squamous master protocol LungMAP.

作者: Vassiliki Papadimitrakopoulou , Mary Weber Redman , David R. Gandara , Fred R. Hirsch , Philip C. Mack

DOI: 10.1200/JCO.2018.36.15_SUPPL.9019

关键词:

摘要: 9019Background: Lung-MAP (S1400) is an umbrella protocol for genomic screening of previously treated squamous cell lung cancer patients and evaluation targeted therapies in biomarker-matched gro...

参考文章(0)